Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **topical analgesic combination** containing diclofenac (a nonsteroidal anti-inflammatory drug, NSAID), menthol (a counterirritant), and methyl salicylate (a counterirritant and salicylate). Diclofenac reduces pain and inflammation by inhibiting cyclooxygenase (COX) enzymes, lowering prostaglandin synthesis. Menthol and methyl salicylate provide rapid cooling and warming sensations, primarily distracting from pain via counterirritant effects and by interfering with pain signal transmission at the skin and superficial nerves. Methyl salicylate is also metabolized locally to salicylic acid, contributing further anti-inflammatory properties. The combination is mainly used for temporary relief of minor aches and pains of muscles and joints, e.g., arthritis, simple backache, strains, sprains, and bruises. It is available as a cream, gel, spray, or patch for adults and children over 12 years[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diclofenac + menthol + methyl salicylate.